NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
0.970
+0.020 (2.11%)
Dec 20, 2024, 4:00 PM EST - Market closed
NextCure Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
Revenue | - | - | - | - | 22.38 | 6.35 | Upgrade
|
Revenue Growth (YoY) | - | - | - | - | 252.58% | - | Upgrade
|
Cost of Revenue | - | - | - | - | 46.55 | 34.22 | Upgrade
|
Gross Profit | - | - | - | - | -24.18 | -27.87 | Upgrade
|
Selling, General & Admin | 16.13 | 19.71 | 21.71 | 20.57 | 17.05 | 9.61 | Upgrade
|
Research & Development | 44.41 | 47.93 | 54.2 | 50.19 | - | - | Upgrade
|
Operating Expenses | 60.54 | 67.64 | 75.91 | 70.77 | 17.05 | 9.61 | Upgrade
|
Operating Income | -60.54 | -67.64 | -75.91 | -70.77 | -41.23 | -37.48 | Upgrade
|
Interest Expense | - | - | - | -0.08 | -0.18 | -0.21 | Upgrade
|
Interest & Investment Income | 4.57 | 4.91 | 1.17 | 1.4 | 4.74 | 3.95 | Upgrade
|
EBT Excluding Unusual Items | -55.98 | -62.72 | -74.74 | -69.45 | -36.67 | -33.74 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | 0.01 | 0.06 | 0.07 | - | Upgrade
|
Pretax Income | -58.52 | -62.72 | -74.73 | -69.39 | -36.6 | -33.74 | Upgrade
|
Net Income | -58.52 | -62.72 | -74.73 | -69.39 | -36.6 | -33.74 | Upgrade
|
Net Income to Common | -58.52 | -62.72 | -74.73 | -69.39 | -36.6 | -33.74 | Upgrade
|
Shares Outstanding (Basic) | 28 | 28 | 28 | 28 | 28 | 16 | Upgrade
|
Shares Outstanding (Diluted) | 28 | 28 | 28 | 28 | 28 | 16 | Upgrade
|
Shares Change (YoY) | 0.48% | 0.33% | 0.46% | 0.30% | 75.41% | 1045.78% | Upgrade
|
EPS (Basic) | -2.09 | -2.25 | -2.69 | -2.51 | -1.33 | -2.15 | Upgrade
|
EPS (Diluted) | -2.09 | -2.25 | -2.69 | -2.51 | -1.33 | -2.15 | Upgrade
|
Free Cash Flow | -45.03 | -53.79 | -56 | -59.64 | -52.09 | -38.99 | Upgrade
|
Free Cash Flow Per Share | -1.61 | -1.93 | -2.02 | -2.16 | -1.89 | -2.48 | Upgrade
|
Gross Margin | - | - | - | - | -108.03% | - | Upgrade
|
Operating Margin | - | - | - | - | -184.22% | -590.55% | Upgrade
|
Profit Margin | - | - | - | - | -163.57% | -531.54% | Upgrade
|
Free Cash Flow Margin | - | - | - | - | -232.76% | -614.37% | Upgrade
|
EBITDA | -57.53 | -63.95 | -71.79 | -66.59 | -37.81 | -34.79 | Upgrade
|
EBITDA Margin | - | - | - | - | -168.97% | - | Upgrade
|
D&A For EBITDA | 3.02 | 3.68 | 4.12 | 4.18 | 3.41 | 2.69 | Upgrade
|
EBIT | -60.54 | -67.64 | -75.91 | -70.77 | -41.23 | -37.48 | Upgrade
|
EBIT Margin | - | - | - | - | -184.22% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.